Literature DB >> 24797994

Frequency of apnea and respiratory viruses in infants with bronchiolitis.

Silvia Ricart1, Nuria Rovira, Juan Jose Garcia-Garcia, Tomas Pumarola, Marti Pons, Carmen Muñoz-Almagro, Maria Angeles Marcos.   

Abstract

The frequency of apnea in infants <12 months of age admitted with acute bronchiolitis was 5.16% (95% confidence interval: 3.94-6.72). Most commonly detected viruses in the 51 apneic infants were respiratory syncytial virus (33.3%), rhinovirus (13.7%) and viral coinfections (23.5%). Young age and prematurity were the main risk factors for apnea independent of the respiratory syncytial virus status. Non-respiratory syncytial virus infants had a higher rate of prematurity.

Entities:  

Mesh:

Year:  2014        PMID: 24797994     DOI: 10.1097/INF.0000000000000365

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Derivation of Candidate Clinical Decision Rules to Identify Infants at Risk for Central Apnea.

Authors:  Paul Walsh; Pádraig Cunningham; Sabrina Merchant; Nicholas Walker; Jacquelyn Heffner; Lucas Shanholtzer; Stephen J Rothenberg
Journal:  Pediatrics       Date:  2015-10-19       Impact factor: 7.124

2.  High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: a multicenter randomized controlled trial (TRAMONTANE study).

Authors:  Christophe Milési; Sandrine Essouri; Robin Pouyau; Jean-Michel Liet; Mickael Afanetti; Aurélie Portefaix; Julien Baleine; Sabine Durand; Clémentine Combes; Aymeric Douillard; Gilles Cambonie
Journal:  Intensive Care Med       Date:  2017-01-26       Impact factor: 17.440

Review 3.  Caffeine therapy in preterm infants.

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  World J Clin Pediatr       Date:  2015-11-08

Review 4.  Prematurity and the burden of influenza and respiratory syncytial virus disease.

Authors:  Bernhard Resch; Stefan Kurath-Koller; Monika Eibisberger; Werner Zenz
Journal:  World J Pediatr       Date:  2015-11-19       Impact factor: 2.764

5.  Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant Death.

Authors:  Chantel D Sloan; Tebeb Gebretsadik; Christian Rosas-Salazar; Pingsheng Wu; Kecia N Carroll; Edward Mitchel; Larry J Anderson; Emma K Larkin; Tina V Hartert
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

Review 6.  Apparent life-threatening event in infancy.

Authors:  Hee Joung Choi; Yeo Hyang Kim
Journal:  Korean J Pediatr       Date:  2016-09-21

7.  Respiratory syncytial virus hospitalization in children in northern Spain.

Authors:  Natividad Viguria; Iván Martínez-Baz; Laura Moreno-Galarraga; Luis Sierrasesúmaga; Blanca Salcedo; Jesús Castilla
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

8.  Paediatric apnoeas are not related to a specific respiratory virus, and parental reports predict hospitalisation.

Authors:  J O Wishaupt; Ean van den Berg; T van Wijk; T van der Ploeg; F G A Versteegh; N G Hartwig
Journal:  Acta Paediatr       Date:  2016-03-17       Impact factor: 2.299

9.  Hospitalizations for viral respiratory infections in children under 2 years of age: epidemiology and in-hospital complications.

Authors:  Jessie N Zurita-Cruz; Alejandro Gutierrez-Gonzalez; Leticia Manuel-Apolinar; José Esteban Fernández-Gárate; María Luisa Arellano-Flores; Roberto Alejandro Correa Gonzalez; Guillermo Vázquez-Rosales; Rocio Sanchez-Armas; Nelly Cisneros-González
Journal:  BMC Pediatr       Date:  2020-06-09       Impact factor: 2.125

10.  Mistrial or Misdiagnosis: The Importance of Autopsy and Histopathological Examination in Cases of Sudden Infant Bronchiolitis-Related Death.

Authors:  Giuseppe Bertozzi; Francesca Maglietta; Benedetta Baldari; Livia Besi; Alessandra Torsello; Cira Rosaria Tiziana Di Gioia; Francesco Sessa; Mariarosaria Aromatario; Luigi Cipolloni
Journal:  Front Pediatr       Date:  2020-05-27       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.